These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain. Tomás I, Alvarez M, Limeres J, Otero JL, Saavedra E, López-Meléndez C, Diz P. Oral Microbiol Immunol; 2004 Oct; 19(5):331-5. PubMed ID: 15327647 [Abstract] [Full Text] [Related]
23. Impact of susceptibility to antibiotics of streptococci & enterococci isolated from patients with infective endocarditis on antibiotic treatment. Mihaila-Amrouche L, Schlegel L, Bouvet A, Association pour l'Etude et la Prévention de l'Endocadite Infectieuse (AEPEI) Study Group. Indian J Med Res; 2004 May; 119 Suppl():80-3. PubMed ID: 15232168 [Abstract] [Full Text] [Related]
24. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Jones RN, Sader HS, Fritsche TR, Pottumarthy S. Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923 [Abstract] [Full Text] [Related]
27. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens]. Limia A, Jiménez ML, Delgado T, Sánchez I, López S, López-Brea M. Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307 [Abstract] [Full Text] [Related]
28. [In vitro susceptibility of streptococcus pneumoniae strains isolated from lower respiratory infections in Instituto Nacional del Tórax (INT)]. Soler T, Salamanca L, Arbo G, Molina E. Rev Med Chil; 2002 Mar; 130(3):304-8. PubMed ID: 12043373 [Abstract] [Full Text] [Related]
29. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood]. Rodríguez-Avial C, García MM, Rodríguez-Avial I, Picazo JJ. Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014 [Abstract] [Full Text] [Related]
30. [Carrier rate of Streptococcus pneumoniae and susceptibility thereof to antimicrobial drugs among children in China: a surveillance study in Beijing, Shanghai, and Guangzhou 2000-2002]. Yao KH, Lu Q, Deng L, Yu SJ, Zhang H, Deng QL, Shen XZ, Yang YH. Zhonghua Yi Xue Za Zhi; 2005 Jul 27; 85(28):1957-61. PubMed ID: 16313770 [Abstract] [Full Text] [Related]
31. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE. J Antimicrob Chemother; 2009 Sep 27; 64(3):501-6. PubMed ID: 19584106 [Abstract] [Full Text] [Related]
37. Antistreptococcal activity of Sch 34343, a new penem antibiotic. Yu PK, Washington JA. J Antimicrob Chemother; 1985 Jun 27; 15 Suppl C():67-71. PubMed ID: 3928578 [Abstract] [Full Text] [Related]
38. Viridans streptococci in infective endocarditis: species distribution and susceptibility to antibiotics. Horaud T, Delbos F. Eur Heart J; 1984 Oct 27; 5 Suppl C():39-44. PubMed ID: 6519085 [Abstract] [Full Text] [Related]
39. Clinical streptococci and their sensitivity to enterocins produced by different strains of the species Enterococcus faecium (short communication). Kandricáková A, Lauková A. Acta Microbiol Immunol Hung; 2012 Mar 27; 59(1):21-7. PubMed ID: 22510284 [Abstract] [Full Text] [Related]
40. Microbiological Epidemiology of Invasive Infections Due to Non-Beta-Hemolytic Streptococci, France, 2021. Plainvert C, Matuschek E, Dmytruk N, Gaillard M, Frigo A, Ballaa Y, Biesaga E, Kahlmeter G, Poyart C, Tazi A. Microbiol Spectr; 2023 Jun 15; 11(3):e0016023. PubMed ID: 37199642 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]